Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

被引：0

作者：

Ziegler, David S. ^{[1
]}

Huynh, Van ^{[2
]}

Burke, Michael J. ^{[3
]}

Gore, Lia ^{[4
]}

Locatelli, Franco ^{[5
]}

O'Brien, Maureen M. ^{[6
]}

Kim, Christopher ^{[7
]}

Obreja, Mihaela ^{[7
]}

Morris, Christopher L. ^{[7
]}

Baruchel, Andre ^{[8
,9
]}

机构：

[1] Sydney Childrens Hosp, Randwick, NSW, Australia

[2] Childrens Hosp Orange Cty, Orange, CA 92668 USA

[3] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53226 USA

[4] Univ Colorado, Childrens Hosp Colorado, Aurora, CO USA

[5] IRCCS Bambino Gesu Childrens Hosp, Rome, Italy

[6] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

[8] Hop Univ Robert Debre, AP HP, Paris, France

[9] Univ Paris, Paris, France

来源：

关键词：

D O I：

10.1182/blood-2021-153865

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4403

引用

页数：4